Aster DM Healthcare Ltd - 540975 - Annual General Meeting To Be Held On Thursday, 29Th August, 2024
With reference to the above captioned subject, Please be informed that the Board of Directors at their meeting held on 28th May, 2024 have inter alia approved the convening of 16th Annual General Meeting of the Company on Thursday, 29th August, 2024 through video conference and/or other audio visual means. Aster DM Healthcare Ltd - 540975 - Corporate Action-Board approves Dividend
Please be informed that the Board of Directors of the Company at their meeting held on 28th May, 2024 has approved the recommendation of the final dividend for the Financial Year ended 31st March, 2024, subject to the approval of the Shareholders at the ensuing Annual General meeting. We request you to kindly take the above said information on record. Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Change in Directorate
With reference to the above captioned Subject, Please be informed that the Board of Directors at their meeting held on May 28, 2024 have approved the reappointment of Ms. Alisha Moopen (DIN: 02432525) as the Deputy Managing Director of the Company for a term of 5 years with effect from August 07, 2024 subject to the approval of the shareholders. We request you to kindly take the above said information on record. Aster DM Healthcare Ltd - 540975 - Audited Financial Results For The 4Th Quarter And Year Ended 31St March, 2024
Please be informed that the Board of Directors at their meeting held on 28th May, 2024 have inter alia approved the audited financial results (standalone and consolidated) for the 4th quarter and year ended 31st March, 2024. Kindly take the above said information on record. Aster DM Healthcare Ltd - 540975 - Board Meeting Outcome for For The Meeting Of The Board Of Directors Held On 28Th May, 2024
The Board of Directors at their meeting held on 28th May, 2024 have, inter alia, approved the audited financial results (standalone and consolidated) for the 4th quarter and year ended 31st March 2024, recommended the final dividend and fixed the AGM date. Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Aster DM Healthcare announces 250 crore expansion plans for Aster CMI Hospital
This expansion is in line with Aster's mission of becoming the 3rd largest healthcare player in India within the next 3 years Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
With reference to the above Captioned Subject, Please be informed that the Company is expanding the Aster CMI Hospital located at Bengaluru. We request you to kindly take the above information on record. Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company through its representatives shall be participating in the 'Trinity India 2024 B&K Conference' and shall be meeting various investors on May 30, 2024 at Mumbai. We request you to kindly take the above information on record. Aster DM Healthcare Ltd - 540975 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to aforementioned Regulation, please be informed that on 25th May, 2024 Aster DM Healthcare Limited has entered into Addendum Hospital operation and Management Agreement with Cauvery Medical Centre Private Limited for the expansion of its existing Aster CMI Hospital premises by adding another 350 beds approximately to the existing Hospital. We request you to kindly take the above information on record. Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Earnings Conference Call with analysts/ Investors is scheduled on Wednesday, May 29, 2024 at 11:00 AM (IST) in relation to the Audited Financial Results for the quarter and year ended March 31, 2024. Please find enclosed the details of the proposed Earnings conference-call. We request you to kindly take the above information on record.